Checkpoint Therapeutics, Inc. (CKPT) Financials

CKPT Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2024 5.2 million 17.8 million
June 30, 2024 5.7 million 21.4 million
March 31, 2024 12.0 million 22.2 million
Dec. 31, 2023 5.4 million 18.4 million

CKPT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -11.2 million 1.6 million
June 30, 2024 -6.2 million 567000
March 31, 2024 -6.5 million 709000
Dec. 31, 2023 -6.8 million 672000

CKPT Net Income

No data available :(

CKPT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 4.7 million - -
June 30, 2024 5.0 million - -
March 31, 2024 11.2 million - -
Dec. 31, 2023 4.9 million - -

CKPT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 43.2 million
June 30, 2024 36.5 million
March 31, 2024 32.9 million
Dec. 31, 2023 27.3 million

CKPT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 6.4 million 3.4 million -
June 30, 2024 - 4.5 million 2.2 million -
March 31, 2024 - 8.5 million 2.5 million 100000
Dec. 31, 2023 - 8.3 million 1.9 million 300000

CKPT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 - -
June 30, 2024 41000 4.5 million
March 31, 2024 - 8.5 million
Dec. 31, 2023 6000 8.3 million

CKPT

Price: $4.26

52 week price:
1.80
4.50

Earnings Per Share: -1.28 USD

P/E Ratio: -3.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 87100

Ebitda: -5.9 million

Market Capitalization: 367.7 million

Links: